Hyperforin dicyclohexylammonium salt结构式
|
常用名 | Hyperforin dicyclohexylammonium salt | 英文名 | Hyperforin dicyclohexylammonium salt |
|---|---|---|---|---|
| CAS号 | 238074-03-8 | 分子量 | 718.10300 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C47H75NO4 | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | N/A | |
| 符号 |
GHS05, GHS07, GHS09 |
信号词 | Danger |
Hyperforin dicyclohexylammonium salt用途Hyperforin dicyclohexylammonium salt (Hyperforin DCHA) 是一种瞬时受体典型 6 (TRPC6) 通道激活剂。Hyperforin dicyclohexylammonium salt 通过激活 Ca2+ 传导非选择性典型 TRPC6 通道来调节 Ca2+ 水平。Hyperforin dicyclohexylammonium salt 具有抗抑郁作用。 |
| 英文名 | N-cyclohexylcyclohexanamine,(1R,5R,6R,7S)-2-hydroxy-6-methyl-1,3,7-tris(3-methylbut-2-enyl)-6-(4-methylpent-3-enyl)-5-(2-methylpropanoyl)bicyclo[3.3.1]non-2-ene-4,9-dione |
|---|---|
| 英文别名 | 更多 |
| 描述 | Hyperforin dicyclohexylammonium salt (Hyperforin DCHA) 是一种瞬时受体典型 6 (TRPC6) 通道激活剂。Hyperforin dicyclohexylammonium salt 通过激活 Ca2+ 传导非选择性典型 TRPC6 通道来调节 Ca2+ 水平。Hyperforin dicyclohexylammonium salt 具有抗抑郁作用。 |
|---|---|
| 相关类别 | |
| 体外研究 | 高福林二环己基铵盐(Hyperforin-DCHA)具有多向作用机制。它阻断配体门控(GABA、NMDA和AMPA受体)和电压门控通道(Ca2+、K+和Na+)[2]的电导。 |
| 参考文献 |
| 分子式 | C47H75NO4 |
|---|---|
| 分子量 | 718.10300 |
| 精确质量 | 717.57000 |
| PSA | 83.47000 |
| LogP | 12.62200 |
| 储存条件 | -20°C,密闭,干燥 |
| 符号 |
GHS05, GHS07, GHS09 |
|---|---|
| 信号词 | Danger |
| 危害声明 | H302-H314-H400 |
| 警示性声明 | P273-P280-P305 + P351 + P338-P310 |
| 危险品运输编码 | UN 1759 8 / PGIII |
|
Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy.
Mol. Cancer Ther. 10 , 336-46, (2011) Oncogenic KRAS is found in more than 25% of lung adenocarcinomas, the major histologic subtype of non-small cell lung cancer (NSCLC), and is an important target for drug development. To this end, we g... |
|
|
Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancer.
Clin. Cancer Res. 15 , 6852-61, (2009) Signal transducer and activator of transcription-3 (STAT3) is downstream of growth factor and cytokine receptors, and regulates key oncogenic pathways in non-small cell lung cancer (NSCLC). Activation... |
|
|
Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a.
Cancer Res. 70 , 9185-96, (2010) Increasing evidence points to the functional importance of alternative splice variations in cancer pathophysiology. Two splice variants are derived from the CASP9 gene via the inclusion (Casp9a) or ex... |
| hyperforin dicyclohexylammonium salt |
| Hyp-DCHA Hyperforin-DCHA |
| Hyp-DCHA |
| Hyperforin-DCHA |